Company Filing History:
Years Active: 2013-2020
Title: Innovator Ping Li: A Pioneer in Pharmaceutical Formulations
Introduction
Ping Li, a notable inventor based in Basking Ridge, NJ, has made significant contributions to the field of pharmaceuticals. With a total of six patents to his name, his work primarily focuses on developing effective formulations for treating various proliferative diseases, including solid tumors.
Latest Patents
Among his latest inventions is a patent for pharmaceutical formulations of (S)-methyl(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate, referred to as COMPOUND A. This invention targets solid oral pharmaceutical formulations to aid in the treatment of solid tumor diseases. Additionally, he has developed a method specifically for treating colorectal cancer through the administration of the same formulations, highlighting his commitment to advancing cancer therapies.
Career Highlights
Throughout his career, Ping Li has collaborated with prominent companies such as Novartis AG and Array Biopharma Inc., where he made impactful contributions to drug development and pharmaceutical research. His work reflects his dedication to enhancing treatment options for patients suffering from debilitating diseases.
Collaborations
In his professional journey, Ping Li has worked closely with esteemed colleagues, including Daya Verma and Xiaohong Shen. Their collaborative efforts have further enriched the innovations emerging in the realm of pharmaceutical sciences.
Conclusion
Ping Li stands as a prominent inventor whose contributions to pharmaceutical formulations are poised to influence the future of cancer treatment and patient care. His patents not only exemplify innovation but also demonstrate a commitment to improving healthcare solutions for those affected by serious illnesses.